Skip to content

FDG Uptake in Vaginal Tampons is Due to Urine

Source and Prevention of Urinary Contamination of Vaginal Tampons During 18F-2-fluoro-2-deoxy-D-glucose (FDG) Positron Emission Tomography (PET) Examinations

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01215318
Enrollment
44
Registered
2010-10-06
Start date
2010-02-02
Completion date
2010-09-30
Last updated
2019-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

FDG PET/CT, vaginal tampon, urinary contamination, pitfall

Brief summary

The etiology of FDG uptake in vaginal tampons during PET/CT examinations remains unclear and can potentially impair image interpretation. The aim of this study is to determine the etiology of this artefact and identify potential means how to prevent it.

Detailed description

In this prospective, Institutional Review board approved study we included 44 women referred to FDG PET/CT for staging or follow-up in an oncology setting. All women were provided a normal commercial or modified vaginal tampon with a silicon coated base to be used during examination. Images were analyzed to determine the localization and the FDG uptake in the tampons. Between the uptake phase and imaging, all patients were asked to void. After image acquisition, tampons were individually analyzed for creatinine concentration, blood traces, position relative to the pubococcygeal line, and FDG activity. Statistical significance was determined by means of the Mann-Whitney U test.

Interventions

DEVICEmodified vaginal tampon

modified vaginal tampons versus unmodified vaginal tampons, comparing the urinary contamination

Sponsors

Irene Burger
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Subject, Investigator)

Masking description

randomly assigned to either modified or unmodified tampons

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 48 Years
Healthy volunteers
No

Inclusion criteria

premenopausal women with known or suspected malignancies who regularly used vaginal tampons during menstruation and thus were familiar with their use

Exclusion criteria

No cervical or genital carcinoma. No vaginal infection.

Design outcomes

Primary

MeasureTime frameDescription
Number of FDG Positive Tampoons1 monthNumber of FDG positive Tampoons with an SUV \> 3

Secondary

MeasureTime frameDescription
Tampon Position Relative to the Pubococcygeal Line1 monthmeasure tampon position in regard to the pubococcygeal line to identify if positioning is responsible for urinary contamination.

Countries

Switzerland

Participant flow

Recruitment details

Premenopausal women referred for FDG PET/CT examination for staging or follow up of malign disease, were given a modified or unmodified vaginal tampon during the PET/CT examination.

Pre-assignment details

Women with urogenital carcinoma were excluded.

Participants by arm

ArmCount
Modified Vaginal Tampons
Patients wearing modified vaginal tampons during PET/CT
20
Unmodified Vaginal Tampons
Patients wearing unmodified vaginal tampons during PET/CT
24
Total44

Baseline characteristics

CharacteristicUnmodified Vaginal TamponsModified Vaginal TamponsTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
24 Participants20 Participants44 Participants
Age, Continuous37 years
STANDARD_DEVIATION 8.4
39 years
STANDARD_DEVIATION 7.7
39 years
STANDARD_DEVIATION 8.5
Region of Enrollment
Switzerland
24 participants20 participants44 participants
Sex: Female, Male
Female
24 Participants20 Participants44 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 200 / 24
serious
Total, serious adverse events
0 / 200 / 24

Outcome results

Primary

Number of FDG Positive Tampoons

Number of FDG positive Tampoons with an SUV \> 3

Time frame: 1 month

ArmMeasureValue (NUMBER)
Modified Vaginal TamponsNumber of FDG Positive Tampoons2 FDG positive tampons
Unmodified Vaginal TamponsNumber of FDG Positive Tampoons10 FDG positive tampons
Secondary

Tampon Position Relative to the Pubococcygeal Line

measure tampon position in regard to the pubococcygeal line to identify if positioning is responsible for urinary contamination.

Time frame: 1 month

ArmMeasureValue (MEAN)Dispersion
Modified Vaginal TamponsTampon Position Relative to the Pubococcygeal Line5.9 mmStandard Deviation 17
Unmodified Vaginal TamponsTampon Position Relative to the Pubococcygeal Line5.1 mmStandard Deviation 11

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026